| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 000 | 5 | NIH | 12/13/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $4,539,808 ) |
| | 2023 | 2023 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01HL169760 | Bispecific immunotherapeutic delivery system for lung diseases | 000 | 1 | NIH | 7/21/2023 | $924,314 |
| | 2023 | 2023 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA240703 | Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer | 000 | 5 | NIH | 6/29/2023 | $680,774 |
| | 2023 | 2023 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01CA221775 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy | 000 | 5 | NIH | 6/29/2023 | $2,519,995 |
| | 2023 | 2023 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA237109 | Tumor caveolae-targeted systemic therapy of breast cancer with antibody drug conjugates | 000 | 5 | NIH | 9/8/2023 | $414,724 |
| | 2023 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 000 | 5 | NIH | 5/15/2023 | $0 |
| | 2023 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA193787 | Targeting Caveolae in Breast Tumors | 000 | 5 | NIH | 11/23/2022 | $1 |
|
| Issue Date FY: 2022 ( Subtotal = $3,643,861 ) |
| | 2022 | 2022 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01CA221775 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy | 000 | 4 | NIH | 6/28/2022 | $2,534,428 |
| | 2022 | 2022 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA237109 | Tumor caveolae-targeted systemic therapy of breast cancer with antibody drug conjugates | 000 | 4 | NIH | 8/30/2022 | $414,724 |
| | 2022 | 2022 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA240703 | Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer | 000 | 4 | NIH | 6/27/2022 | $694,745 |
| | 2022 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 000 | 5 | NIH | 7/11/2022 | -$35 |
| | 2022 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA193787 | Targeting Caveolae in Breast Tumors | 000 | 5 | NIH | 2/17/2022 | $0 |
| | 2022 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE | 505 COAST BLVD S | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA193787 | Targeting Caveolae in Breast Tumors | 001 | 5 | NIH | 2/25/2022 | -$1 |
|
| Issue Date FY: 2021 ( Subtotal = $4,256,302 ) |
| | 2021 | 2021 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA240703 | Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer | 000 | 3 | NIH | 6/28/2021 | $722,712 |
| | 2021 | 2021 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA237109 | Tumor caveolae-targeted systemic therapy of breast cancer with antibody drug conjugates | 000 | 3 | NIH | 8/20/2021 | $423,188 |
| | 2021 | 2021 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01CA221775 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy | 000 | 3 | NIH | 7/12/2021 | $2,678,066 |
| | 2021 | 2021 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 000 | 5 | NIH | 3/26/2021 | $432,336 |
| | 2021 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 000 | 5 | NIH | 2/16/2021 | $0 |
| | 2021 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA169644 | Nanodelivery to enhance the imaging and therapy of breast cancer | 000 | 5 | NIH | 8/19/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $4,290,300 ) |
| | 2020 | 2020 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA240703 | Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer | 000 | 2 | NIH | 6/18/2020 | $735,974 |
| | 2020 | 2020 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01CA221775 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy | 000 | 2 | NIH | 8/31/2020 | $2,667,097 |
| | 2020 | 2020 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA237109 | Tumor caveolae-targeted systemic therapy of breast cancer with antibody drug conjugates | 000 | 2 | NIH | 8/13/2020 | $423,188 |
| | 2020 | 2020 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 000 | 4 | NIH | 8/28/2020 | $464,041 |
|
| Issue Date FY: 2019 ( Subtotal = $7,924,797 ) |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 000 | 5 | NIH | 4/29/2019 | $2,697,594 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 000 | 3 | NIH | 3/14/2019 | $444,921 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA169644 | Nanodelivery to enhance the imaging and therapy of breast cancer | 000 | 5 | NIH | 7/19/2019 | $410,491 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01CA221775 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy | 000 | 1 | NIH | 7/8/2019 | $2,788,878 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01CA221775 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy | 001 | 1 | NIH | 7/15/2019 | $0 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA193787 | Targeting Caveolae in Breast Tumors | 000 | 5 | NIH | 8/23/2019 | $410,490 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA240703 | Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer | 000 | 1 | NIH | 6/13/2019 | $749,235 |
| | 2019 | 2019 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA237109 | Tumor caveolae-targeted systemic therapy of breast cancer with antibody drug conjugates | 000 | 1 | NIH | 6/24/2019 | $423,188 |
|
| Issue Date FY: 2018 ( Subtotal = $4,003,287 ) |
| | 2018 | 2018 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 001 | 2 | NIH | 5/23/2018 | $45,908 |
| | 2018 | 2018 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA169644 | Nanodelivery to enhance the imaging and therapy of breast cancer | 000 | 4 | NIH | 5/1/2018 | $423,188 |
| | 2018 | 2018 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 000 | 4 | NIH | 2/23/2018 | $2,643,873 |
| | 2018 | 2018 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 001 | 4 | NIH | 7/14/2018 | $53,958 |
| | 2018 | 2018 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA193787 | Targeting Caveolae in Breast Tumors | 000 | 4 | NIH | 8/16/2018 | $423,188 |
| | 2018 | 2018 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 000 | 2 | NIH | 3/9/2018 | $413,172 |
|
| Issue Date FY: 2017 ( Subtotal = $3,901,465 ) |
| | 2017 | 2017 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 11211 SORRENTO VALLEY RD STE X | SAN DIEGO | CA | 92121-1325 | SAN DIEGO | USA | P01HL119165 | Novel Targeted Therapies for Pulmonary Fibrosis | 000 | 3 | NIH | 2/27/2017 | $2,698,059 |
| | 2017 | 2017 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA169644 | Nanodelivery to enhance the imaging and therapy of breast cancer | 001 | 3 | NIH | 6/9/2017 | $42,319 |
| | 2017 | 2017 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 11211 SORRENTO VALLEY RD STE X | SAN DIEGO | CA | 92121-1325 | SAN DIEGO | USA | R01CA215157 | Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy | 000 | 1 | NIH | 3/10/2017 | $470,380 |
| | 2017 | 2017 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | U01CA193787 | Targeting Caveolae in Breast Tumors | 000 | 3 | NIH | 8/23/2017 | $309,838 |
| | 2017 | 2017 | PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE | 505 COAST BLVD S STE 209 | LA JOLLA | CA | 92037-4614 | SAN DIEGO | USA | R01CA169644 | Nanodelivery to enhance the imaging and therapy of breast cancer | 000 | 3 | NIH | 4/28/2017 | $380,869 |
|
|
